Coeliac disease remains an important cause of malabsorption in children. Definitive diagnosis requires histological confirmation by jejunal biopsy showing subtotal villous atrophy, increased numbers of intraepithelial lymphocytes, and crypt cell hyperplasia. Small intestinal biopsy is invasive, involves a period of fasting, and requires exposure to radiation to confirm correct positioning of the capsule. Many children undergo biopsies that subsequently prove to be negative, and thus various non-invasive tests have been proposed as screening tests. Tests such as xylose absorption and differential sugar permeability lack specificity and may be falsely positive in children with other causes of small intestinal mucosal damage.' Recently, attention has been directed towards the measurement of serum antibodies to gliadin,2-9 smooth muscle endomysium, 81 reticulin,12-14 and human jejunum,'5 with different workers finding varying degrees of specificity and sensitivity for these tests Patients and methods A prospective study was designed to determine the prevalence of salivary and serum IgA AGA and serum IgG AGA in groups of children with coeliac disease, other gastrointestinal disorders, cystic fibrosis, and in children with no evidence of gut disease.
PATIENTS
There were 141 patients, divided into five groups, in whom AGA were measured. In group A were 19 patients (age range 9 months-14 years, median 5 years) who had coeliac disease proved by biopsy: they comprised 16 studied at presentation and three after gluten challenge. In group B were nine children (age range 2-18 years, median 6 years) who had established coeliac disease and were clinically well on a gluten free diet. Both these groups had satisfied the revised European Society of Paediatric Gastroenterology and Nutrition (ESPGAN) criteria for diagnosis.22 In group C were 60 children (age range 6 months-15 years, median 4 years) undergoing jejunal biopsy who subsequently proved to have conditions other than coeliac disease (such as cows' milk or soy protein intolerance or toddler diarrhoea). In group D were nine children (age range 1-13 years, median 9 years) with cystic fibrosis. In group E were 44 children (age range 6 months to 18 years, median 4 years) with no clinical evidence of gastrointestinal disease who were having blood tests for other reasons. Small intestinal histology was not available for the last two groups of children.
It proved impossible to collect both serum and saliva in every patient in each group and the results represent all the data available in each group of patients. Simultaneous saliva and serum data were, however, available in eight patients. The district ethical committee had approved the study and consent was obtained from all parents and from older children if possible.
METHODS
Whole unstimulated saliva was collected from the patients. Older children were able to spit directly into sterile containers and, for younger children and infants, a suction catheter attached to gentle wall suction was used to obtain the specimens. At least 1 ml was obtained from each child. The saliva was heated at 56°C for 30 minutes to inactivate complement and enzyme activity, and centrifuged at 1000 g for 20 minutes to remove particulate matter. The supernatant was stored at -20°C until the assays were performed. Salivary IgA AGA were assayed using a standard enzyme linked immunosorbent assay (ELISA) technique as previously described.21
For the serum assays, a commercial gliadin IgA ELISA test kit (Pharmacia) was used and a similar ELISA technique (in another laboratory) was used to measure serum IgG AGA. The results for each assay were expressed in optical density units and the results of saliva and serum antibodies from each group were compared and analysed by non-parametric means using the Mann-Whitney U test. 2) . The 'normal' reference range quoted for the test by Pharmacia is 0-25 and, using this range, three of the 15 patients with untreated coeliac disease had normal values (false negative results), giving the test a sensitivity of 80%. All the patients in the other groups, with one exception, gave results within the quoted normal range, yielding a specificity of 99%.
Results
In the eight patients with coeliac disease in whom saliva and serum AGA were studied simultaneously, there was no correlation between the individual results for salivary and serum IgA. Thus some patients registered high levels of AGA in saliva and low levels in serum, and vice versa.
Serum IgG AGA (fig 3) Unfortunately, data were available from a relatively small number ofpatients and, although the median value in the group with untreated coeliac disease was much higher than in the other groups, there was considerable overlap a) with very high values occurring in children who did not have coeliac disease. There were no age related differences in values of AGA in saliva or serum in any of the groups (data not shown).
Discussion
The definitive diagnosis of coeliac disease still requires small intestinal biopsy, which is invasive and time consuming, and many negative biopsies are performed each year. Early diagnosis of the condition is important, not only in avoiding the clinical consequences of malabsorption and suboptimal growth, but also because treatment with a gluten free diet appears to reduce the subsequent risk of small intestinal malignancy. 23 In order to minimise the number of negative biopsies, several non-invasive screening tests have been employed and, of these, the use of serological markers has proved to be the most fruitful. We would like to thank Dr Robert Newcombe for his assistance with statistical analysis and Miss Leah Gallivan for typing the manuscript.
